![Assaf Oron](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Assaf Oron
Corporate Officer/Principal presso BIOMX INC.
Profilo
Assaf Oron is currently the Chief Executive Officer & Director at Evofuel Ltd.
and the Chief Business Officer at BiomX, Inc. He previously served as the Chief Executive Officer at Chondrocyte Ltd., Senior Project Manager at POC Management Consulting, Executive VP-Corporate Development at Evogene Ltd., and Chief Business Officer at BiomX Ltd.
Mr. Oron received his undergraduate and graduate degrees from Tel-Aviv University.
Posizioni attive di Assaf Oron
Società | Posizione | Inizio |
---|---|---|
BIOMX INC. | Corporate Officer/Principal | 28/10/2019 |
Evofuel Ltd. | Amministratore Delegato | 01/01/2012 |
Precedenti posizioni note di Assaf Oron
Società | Posizione | Fine |
---|---|---|
BiomX Ltd.
![]() BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Corporate Officer/Principal | 01/10/2019 |
EVOGENE LTD. | Corporate Officer/Principal | 01/01/2017 |
Chondrocyte Ltd. | Amministratore Delegato | 01/01/2006 |
POC Management Consulting | Corporate Officer/Principal | 01/01/2003 |
Formazione di Assaf Oron
Tel-Aviv University | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
EVOGENE LTD. | Health Technology |
BIOMX INC. | Health Technology |
Aziende private | 4 |
---|---|
POC Management Consulting | |
Evofuel Ltd. | |
Chondrocyte Ltd. | |
BiomX Ltd.
![]() BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |
- Borsa valori
- Insiders
- Assaf Oron